Commercialization & Reimbursement Consulting
XIFIN provides a comprehensive range of reimbursement and commercialization consulting services for molecular diagnostics.
We help early stage companies bring new molecular diagnostics and advanced diagnostic device concepts to market effectively, as well as guide mature companies on how to improve reimbursement processes to increase profitability. We also work with investors looking to inject capital in molecular diagnostics and medical device ventures with high potential.
It’s Easy To Get Started
Commercialization and Reimbursement Consulting offers flexibility to customize an engagement that addresses your needs and your budget. We can work with you on a specific need, such as developing a commercialization strategy, or we can work with you on an ongoing basis to ensure that our clients are always up to date on any issues that may impact their business, including market and regulatory changes. We help you stay ahead of change and ensure that you have the operational agility to handle rapid growth.